Hitachi to Develop 'Confidential AI Platform' to Accelerate Open Innovation in AI Drug Discovery. Full-Scale Co-Creation with MOLCURE Toward Service Provision
NQ Score
78/100
N1 Content Completeness
7
AI Summary (NQ-processed)
Hitachi and MOLCURE have fully launched their co-creation to develop a 'Confidential AI Platform' to accelerate AI-driven drug discovery for biopharmaceuticals.